UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
BTCY holding history
Biotricity Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BTCY overviewAll 13F holders of BTCYFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −9,225−100.0% | Sold out | Holders |
| Q2 2024 | 9,225 | $8.30K | <0.1% | +9,225 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −1,416−100.0% | Sold out | Holders |
| Q3 2023 | 1,416 | $3.03K | <0.1% | +734+107.6% | AddedConverted for a 1-for-6 split | Holders |
| Q2 2023 | 4,093 | $2.61K | <0.1% | +4,093 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −15,735−100.0% | Sold out | Holders |
| Q4 2022 | 15,735 | $7.08K | <0.1% | +14,735+1,473.5% | Added | Holders |
| Q3 2022 | 1,000 | $1.00K | <0.1% | −5,098−83.6% | Reduced | Holders |
| Q2 2022 | 6,098 | $11.0K | <0.1% | −2,767−31.2% | Reduced | Holders |
| Q1 2022 | 8,865 | $20.0K | <0.1% | +3,033+52.0% | Added | Holders |
| Q4 2021 | 5,832 | $23.0K | <0.1% | +5,832 | New | Holders |